In agreement with these observations, IL-33-deficient mice showed no difference from WT mice in experimental autoimmune encephalomyelitis, a model of multiple sclerosis, Con A-induced hepatitis, or streptozocyn-induced diabetes [30]. This evidence concerns the gene IL33 and multiple sclerosis.